Chelonia mydas isolate rCheMyd1 chromosome 22, rCheMyd1.pri.v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Americhelydia; Chelonioidea; Cheloniidae; Chelonia.
REFSEQ INFORMATION: The reference sequence is identical to\nCM026919.2.\nOn Sep 23, 2021 this sequence version replaced NC_051262.1.\nAssembly name: rCheMyd1.pri.v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/07/15. The original whole-genome shotgun project has the\naccession JADCQM000000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 28-MAY-2021\nAssembly Method :: FALCON 1.3.0 v. 2018.31.08-03.06;\n FALCON-Unzip v. 1.2.0 6.0.0.47841;\n purge_dups v. github\n ca23030ccf4254dfd2d3a5ea90d0eed41c24f88b\n ca23030ccf4254dfd2d3a5ea90d0eed41c24f88b;\n Scaff10x v. 4.1.0; Bionano Solve v.\n 3.2.1_04122018; Salsa2 HiC v. 2.2; Arrow\n polishing and gap filling v.\n SMRTLink7.0.1; Longranger Align v. 2.2.2;\n freebayes v. 1.3.1; gEVAL manual curation\n v. 2021-05-28; VGP assembly pipeline v.\n 1.6\nAssembly Name :: rCheMyd1.pri.v2\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 60.0x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chelonia mydas Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon AUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC119564011, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC119564011, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC119564011, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 271, transcript variant X9
COORDINATES: polyA evidence [ECO:0006239]
zinc finger protein 271, transcript variant X1
zinc finger protein 271, transcript variant X8
zinc finger protein 271, transcript variant X3
zinc finger protein 271, transcript variant X4
zinc finger protein 271, transcript variant X7
zinc finger protein 271, transcript variant X10
zinc finger protein 271, transcript variant X2
zinc finger protein 271, transcript variant X5
zinc finger protein 271, transcript variant X6
zinc finger protein 501, transcript variant X7
zinc finger protein 501, transcript variant X2
zinc finger protein 501, transcript variant X4
zinc finger protein 501, transcript variant X3
zinc finger protein 501, transcript variant X1
zinc finger protein 501, transcript variant X5
zinc finger protein 501, transcript variant X6
zinc finger protein 3 homolog, transcript variant X2
zinc finger protein 3 homolog, transcript variant X1
zinc finger protein 3 homolog, transcript variant X3
fasciculation and elongation protein zeta 1, transcript variant X2
fasciculation and elongation protein zeta 1, transcript variant X1
fasciculation and elongation protein zeta 1, transcript variant X4
fasciculation and elongation protein zeta 1, transcript variant X6
fasciculation and elongation protein zeta 1, transcript variant X3
fasciculation and elongation protein zeta 1, transcript variant X5
fasciculation and elongation protein zeta 1, transcript variant X7
fasciculation and elongation protein zeta-1 isoform X1
fasciculation and elongation protein zeta-1 isoform X2
fasciculation and elongation protein zeta-1 isoform X3
PBX/knotted 1 homeobox 2, transcript variant X6
PBX/knotted 1 homeobox 2, transcript variant X4
PBX/knotted 1 homeobox 2, transcript variant X1
PBX/knotted 1 homeobox 2, transcript variant X3
PBX/knotted 1 homeobox 2, transcript variant X5
PBX/knotted 1 homeobox 2, transcript variant X2
transmembrane protein 218, transcript variant X5
transmembrane protein 218, transcript variant X4
transmembrane protein 218, transcript variant X2
transmembrane protein 218, transcript variant X3
transmembrane protein 218, transcript variant X1
solute carrier family 37 member 2, transcript variant X2
solute carrier family 37 member 2, transcript variant X1
glucose-6-phosphate exchanger SLC37A2 isoform X2
glucose-6-phosphate exchanger SLC37A2 isoform X1
coiled-coil domain containing 15, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain containing 15, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain-containing protein 15 isoform X3
coiled-coil domain containing 15, transcript variant X2
coiled-coil domain containing 15, transcript variant X4
coiled-coil domain containing 15, transcript variant X5
coiled-coil domain containing 15, transcript variant X1
coiled-coil domain containing 15, transcript variant X6
coiled-coil domain-containing protein 15 isoform X4
coiled-coil domain-containing protein 15 isoform X5
coiled-coil domain-containing protein 15 isoform X1
coiled-coil domain-containing protein 15 isoform X2
hepatic and glial cell adhesion molecule, transcript variant X5
hepatic and glial cell adhesion molecule, transcript variant X6
hepatic and glial cell adhesion molecule, transcript variant X1
hepatic and glial cell adhesion molecule, transcript variant X4
hepatic and glial cell adhesion molecule, transcript variant X3
hepatic and glial cell adhesion molecule, transcript variant X7
hepatic and glial cell adhesion molecule, transcript variant X2
hepatocyte cell adhesion molecule isoform X1
hepatic and glial cell adhesion molecule, transcript variant X8
hepatocyte cell adhesion molecule isoform X2
roundabout guidance receptor 4, transcript variant X1
roundabout guidance receptor 4, transcript variant X2
roundabout guidance receptor 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
roundabout guidance receptor 4, transcript variant X4
roundabout guidance receptor 4, transcript variant X3
roundabout guidance receptor 3, transcript variant X4
roundabout guidance receptor 3, transcript variant X3
roundabout guidance receptor 3, transcript variant X2
roundabout guidance receptor 3, transcript variant X7
roundabout guidance receptor 3, transcript variant X6
roundabout guidance receptor 3, transcript variant X5
roundabout guidance receptor 3, transcript variant X1
uncharacterized LOC122463581, transcript variant X2
uncharacterized LOC122463581, transcript variant X1
Myb/SANT DNA binding domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X1
Myb/SANT DNA binding domain containing 2, transcript variant X2
Myb/SANT DNA binding domain containing 2, transcript variant X3
myb/SANT-like DNA-binding domain-containing protein 2 isoform X4
myb/SANT-like DNA-binding domain-containing protein 2 isoform X1
myb/SANT-like DNA-binding domain-containing protein 2 isoform X2
myb/SANT-like DNA-binding domain-containing protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
endothelial cell-selective adhesion molecule
V-set and immunoglobulin domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
V-set and immunoglobulin domain-containing protein 2
sialic acid acetylesterase, transcript variant X2
sialic acid acetylesterase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
RNA pseudouridine synthase D4, transcript variant X1
RNA pseudouridine synthase D4, transcript variant X2
mitochondrial RNA pseudouridine synthase RPUSD4 isoform X1
mitochondrial RNA pseudouridine synthase RPUSD4 isoform X2
RNA pseudouridine synthase D4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
mitochondrial RNA pseudouridine synthase RPUSD4 isoform X3
HYLS1 centriolar and ciliogenesis associated, transcript variant X1
pseudouridine synthase 3, transcript variant X1
pseudouridine synthase 3, transcript variant X3
pseudouridine synthase 3, transcript variant X2
HYLS1 centriolar and ciliogenesis associated, transcript variant X2
DEAD-box helicase 25, transcript variant X1
DEAD-box helicase 25, transcript variant X2
ATP-dependent RNA helicase DDX25 isoform X1
ATP-dependent RNA helicase DDX25 isoform X2
DEAD-box helicase 25, transcript variant X3
ATP-dependent RNA helicase DDX25 isoform X3
V-set and immunoglobulin domain containing 10 like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
V-set and immunoglobulin domain-containing protein 10-like 2
cell adhesion associated, oncogene regulated, transcript variant X2
cell adhesion associated, oncogene regulated, transcript variant X1
cell adhesion associated, oncogene regulated, transcript variant X3
cell adhesion associated, oncogene regulated, transcript variant X4
cell adhesion associated, oncogene regulated, transcript variant X5
cell adhesion molecule-related/down-regulated by oncogenes isoform X1
cell adhesion molecule-related/down-regulated by oncogenes isoform X2
prostate and testis expressed protein 4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine/threonine-protein kinase Chk1
STT3 oligosaccharyltransferase complex catalytic subunit A
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A
EI24 autophagy associated transmembrane protein, transcript variant X2
EI24 autophagy associated transmembrane protein, transcript variant X1
EI24 autophagy associated transmembrane protein, transcript variant X3
etoposide-induced protein 2.4 homolog isoform X1
etoposide-induced protein 2.4 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
pulmonary surfactant-associated protein C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pulmonary surfactant-associated protein C-like isoform X2
pulmonary surfactant-associated protein C-like, transcript variant X1
pulmonary surfactant-associated protein C-like isoform X1
pulmonary surfactant-associated protein C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 118 member B, transcript variant X6
family with sequence similarity 118 member B, transcript variant X2
family with sequence similarity 118 member B, transcript variant X5
family with sequence similarity 118 member B, transcript variant X1
family with sequence similarity 118 member B, transcript variant X4
family with sequence similarity 118 member B, transcript variant X3
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
signal recognition particle receptor subunit alpha
FAD dependent oxidoreductase domain containing 1
FAD-dependent oxidoreductase domain-containing protein 1
TIR domain containing adaptor protein, transcript variant X3
TIR domain containing adaptor protein, transcript variant X8
TIR domain containing adaptor protein, transcript variant X7
TIR domain containing adaptor protein, transcript variant X4
TIR domain containing adaptor protein, transcript variant X2
toll/interleukin-1 receptor domain-containing adapter protein isoform X2
TIR domain containing adaptor protein, transcript variant X5
TIR domain containing adaptor protein, transcript variant X1
TIR domain containing adaptor protein, transcript variant X6
toll/interleukin-1 receptor domain-containing adapter protein isoform X1
toll/interleukin-1 receptor domain-containing adapter protein isoform X3
decapping enzyme, scavenger, transcript variant X1
decapping enzyme, scavenger, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X14
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X24
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X12
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X18
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X26
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X6
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X6
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X13
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X7
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X11
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X19
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X23
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X7
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X27
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X5
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X8
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X22
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X5
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X8
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X10
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X9
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X16
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X21
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X15
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X17
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X4
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X20
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X1
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X9
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X25
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X10
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X3
kirre like nephrin family adhesion molecule 3, transcript variant X2
kirre like nephrin family adhesion molecule 3, transcript variant X1
kirre like nephrin family adhesion molecule 3, transcript variant X3
ETS proto-oncogene 1, transcription factor, transcript variant X1
ETS proto-oncogene 1, transcription factor, transcript variant X2
ETS proto-oncogene 1, transcription factor, transcript variant X3
ETS proto-oncogene 1, transcription factor, transcript variant X4
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X3
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X5
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X7
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X6
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X4
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X9
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X1
Friend leukemia integration 1 transcription factor isoform X1
Friend leukemia integration 1 transcription factor isoform X4
Friend leukemia integration 1 transcription factor isoform X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X12
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X10
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X8
Friend leukemia integration 1 transcription factor isoform X3
Friend leukemia integration 1 transcription factor isoform X5
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X11
Friend leukemia integration 1 transcription factor isoform X6
potassium inwardly rectifying channel subfamily J member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium inwardly rectifying channel subfamily J member 1, transcript variant X1
potassium inwardly rectifying channel subfamily J member 1, transcript variant X2
potassium inwardly rectifying channel subfamily J member 1, transcript variant X3
ATP-sensitive inward rectifier potassium channel 1
potassium inwardly rectifying channel subfamily J member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium inwardly rectifying channel subfamily J member 1, transcript variant X5
G protein-activated inward rectifier potassium channel 4
Rho GTPase activating protein 32, transcript variant X4
Rho GTPase activating protein 32, transcript variant X2
Rho GTPase activating protein 32, transcript variant X3
Rho GTPase activating protein 32, transcript variant X1
Rho GTPase activating protein 32, transcript variant X5
rho GTPase-activating protein 32 isoform X4
rho GTPase-activating protein 32 isoform X2
rho GTPase-activating protein 32 isoform X3
rho GTPase-activating protein 32 isoform X1
rho GTPase-activating protein 32 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122463576, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122463576, transcript variant X1
transmembrane protein 45B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 45B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 45B, transcript variant X2
transmembrane protein 45B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
uncharacterized LOC122463540, transcript variant X1
uncharacterized LOC122463540, transcript variant X2
amyloid beta precursor like protein 2, transcript variant X10
amyloid beta precursor like protein 2, transcript variant X7
amyloid beta precursor like protein 2, transcript variant X3
amyloid beta precursor like protein 2, transcript variant X6
amyloid beta precursor like protein 2, transcript variant X8
amyloid beta precursor like protein 2, transcript variant X9
amyloid beta precursor like protein 2, transcript variant X4
amyloid beta precursor like protein 2, transcript variant X1
amyloid beta precursor like protein 2, transcript variant X5
amyloid beta precursor like protein 2, transcript variant X2
PR domain zinc finger protein 10 isoform X2
PR domain zinc finger protein 10 isoform X4
PR domain zinc finger protein 10 isoform X1
PR domain zinc finger protein 10 isoform X5
PR domain zinc finger protein 10 isoform X3
nuclear factor related to kappaB binding protein, transcript variant X4
nuclear factor related to kappaB binding protein, transcript variant X6
nuclear factor related to kappaB binding protein, transcript variant X5
nuclear factor related to kappaB binding protein, transcript variant X1
nuclear factor related to kappaB binding protein, transcript variant X3
nuclear factor related to kappaB binding protein, transcript variant X2
nuclear factor related to kappaB binding protein, transcript variant X7
nuclear factor related to kappa-B-binding protein isoform X1
nuclear factor related to kappa-B-binding protein isoform X3
nuclear factor related to kappa-B-binding protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
ST14 transmembrane serine protease matriptase, transcript variant X4
ST14 transmembrane serine protease matriptase, transcript variant X2
ST14 transmembrane serine protease matriptase, transcript variant X1
suppressor of tumorigenicity 14 protein isoform X1
suppressor of tumorigenicity 14 protein isoform X2
ST14 transmembrane serine protease matriptase, transcript variant X5
ST14 transmembrane serine protease matriptase, transcript variant X3
suppressor of tumorigenicity 14 protein isoform X3
uncharacterized LOC119564013, transcript variant X3
uncharacterized LOC119564013, transcript variant X1
uncharacterized LOC119564013, transcript variant X2
uncharacterized LOC119564013, transcript variant X4
uncharacterized LOC119564013, transcript variant X5
zinc finger and BTB domain containing 44, transcript variant X10
zinc finger and BTB domain containing 44, transcript variant X4
zinc finger and BTB domain-containing protein 44 isoform X2
zinc finger and BTB domain containing 44, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 44 isoform X3
zinc finger and BTB domain containing 44, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 44 isoform X5
zinc finger and BTB domain containing 44, transcript variant X12
zinc finger and BTB domain containing 44, transcript variant X2
zinc finger and BTB domain containing 44, transcript variant X1
zinc finger and BTB domain containing 44, transcript variant X3
zinc finger and BTB domain-containing protein 44 isoform X1
zinc finger and BTB domain-containing protein 44 isoform X4
ADAM metallopeptidase with thrombospondin type 1 motif 8
A disintegrin and metalloproteinase with thrombospondin motifs 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
opioid binding protein/cell adhesion molecule like, transcript variant X2
opioid binding protein/cell adhesion molecule like, transcript variant X1
opioid binding protein/cell adhesion molecule like, transcript variant X3
opioid binding protein/cell adhesion molecule like, transcript variant X4
opioid-binding protein/cell adhesion molecule isoform X2
opioid-binding protein/cell adhesion molecule isoform X1
opioid-binding protein/cell adhesion molecule isoform X4
opioid-binding protein/cell adhesion molecule isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 48% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: spermatogenesis-associated protein 19, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein turtle homolog B
uncharacterized LOC122463545, transcript variant X2
uncharacterized LOC122463545, transcript variant X1
non-SMC condensin II complex subunit D3, transcript variant X1
non-SMC condensin II complex subunit D3, transcript variant X2
condensin-2 complex subunit D3 isoform X2
condensin-2 complex subunit D3 isoform X1
vacuolar protein sorting-associated protein 26B
acyl-CoA dehydrogenase family member 8, transcript variant X1
acyl-CoA dehydrogenase family member 8, transcript variant X2
isobutyryl-CoA dehydrogenase, mitochondrial isoform X1
isobutyryl-CoA dehydrogenase, mitochondrial isoform X2
galactosidase beta 1 like 2, transcript variant X3
galactosidase beta 1 like 2, transcript variant X1
galactosidase beta 1 like 2, transcript variant X2
beta-galactosidase-1-like protein 2 isoform X1
beta-galactosidase-1-like protein 2 isoform X3
beta-galactosidase-1-like protein 2 isoform X2
galactosidase beta 1 like 2, transcript variant X4
beta-galactosidase-1-like protein 2 isoform X4
beta-1,3-glucuronyltransferase 1, transcript variant X5
beta-1,3-glucuronyltransferase 1, transcript variant X2
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X5
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X2
beta-1,3-glucuronyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta-1,3-glucuronyltransferase 1, transcript variant X7
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X4
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X3
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X6
adventurous-gliding motility protein Z-like
fibrous sheath CABYR-binding protein-like, transcript variant X4
fibrous sheath CABYR-binding protein-like, transcript variant X6
fibrous sheath CABYR-binding protein-like, transcript variant X1
fibrous sheath CABYR-binding protein-like, transcript variant X5
fibrous sheath CABYR-binding protein-like, transcript variant X2
fibrous sheath CABYR-binding protein-like, transcript variant X3
fibrous sheath CABYR-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neurogenic locus notch homolog protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
ATPase H+/K+ transporting non-gastric alpha2 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 150 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium-transporting ATPase alpha chain 2
sodium voltage-gated channel beta subunit 3, transcript variant X1
sodium channel subunit beta-3 isoform X1
sodium voltage-gated channel beta subunit 3, transcript variant X2
sodium voltage-gated channel beta subunit 3, transcript variant X3
sodium channel subunit beta-3 isoform X2
GRAM domain containing 1B, transcript variant X3
GRAM domain containing 1B, transcript variant X5
GRAM domain containing 1B, transcript variant X1
GRAM domain containing 1B, transcript variant X6
GRAM domain containing 1B, transcript variant X2
GRAM domain containing 1B, transcript variant X4
GRAM domain containing 1B, transcript variant X7
GRAM domain containing 1B, transcript variant X8
GRAM domain containing 1B, transcript variant X9
GRAM domain containing 1B, transcript variant X10
uncharacterized LOC119564008, transcript variant X2
uncharacterized LOC119564008, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
heat shock protein family A (Hsp70) member 8
COORDINATES: nucleotide motif:Rfam:12.0:RF00016
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
junctional cadherin complex regulator, transcript variant X3
junctional cadherin complex regulator, transcript variant X1
junctional cadherin complex regulator, transcript variant X2
junctional cadherin complex regulator, transcript variant X4
junctional cadherin complex regulator, transcript variant X5
cytotoxic and regulatory T cell molecule, transcript variant X2
cytotoxic and regulatory T cell molecule, transcript variant X1
cytotoxic and regulatory T-cell molecule isoform X2
cytotoxic and regulatory T-cell molecule isoform X1
ubiquitin associated and SH3 domain containing B, transcript variant X1
ubiquitin associated and SH3 domain containing B, transcript variant X2
ubiquitin associated and SH3 domain containing B, transcript variant X4
ubiquitin associated and SH3 domain containing B, transcript variant X3
ubiquitin associated and SH3 domain containing B, transcript variant X5
ubiquitin-associated and SH3 domain-containing protein B isoform X2
ubiquitin-associated and SH3 domain-containing protein B isoform X1
ubiquitin-associated and SH3 domain-containing protein B isoform X4
ubiquitin-associated and SH3 domain-containing protein B isoform X3
ubiquitin-associated and SH3 domain-containing protein B isoform X5
uncharacterized LOC114021123, transcript variant X1
uncharacterized LOC114021123, transcript variant X2
uncharacterized LOC122463527, transcript variant X1
uncharacterized LOC122463527, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sortilin-related receptor
uncharacterized LOC122463528, transcript variant X2
uncharacterized LOC122463528, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sterol-C5-desaturase, transcript variant X1
sterol-C5-desaturase, transcript variant X3
sterol-C5-desaturase, transcript variant X2
uncharacterized LOC114021125, transcript variant X3
uncharacterized LOC114021125, transcript variant X6
uncharacterized LOC114021125, transcript variant X2
uncharacterized LOC114021125, transcript variant X5
uncharacterized LOC114021125, transcript variant X4
uncharacterized LOC114021125, transcript variant X1
uncharacterized LOC114021125, transcript variant X7
tubulin-specific chaperone cofactor E-like protein, transcript variant X9
tubulin-specific chaperone cofactor E-like protein, transcript variant X4
tubulin-specific chaperone cofactor E-like protein, transcript variant X3
tubulin-specific chaperone cofactor E-like protein, transcript variant X2
tubulin-specific chaperone cofactor E-like protein, transcript variant X1
tubulin-specific chaperone cofactor E-like protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tubulin-specific chaperone cofactor E-like protein, transcript variant X7
tubulin-specific chaperone cofactor E-like protein, transcript variant X8
tubulin-specific chaperone cofactor E-like protein, transcript variant X6
tubulin-specific chaperone cofactor E-like protein isoform X2
uncharacterized LOC114021128, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC114021128, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC114021128, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X1
glutamate ionotropic receptor kainate type subunit 4, transcript variant X4
glutamate ionotropic receptor kainate type subunit 4, transcript variant X3
glutamate ionotropic receptor kainate type subunit 4, transcript variant X2
glutamate receptor ionotropic, kainate 4 isoform X3
glutamate receptor ionotropic, kainate 4 isoform X2
glutamate receptor ionotropic, kainate 4 isoform X1
glutamate ionotropic receptor kainate type subunit 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 12, transcript variant X2
Rho guanine nucleotide exchange factor 12, transcript variant X1
Rho guanine nucleotide exchange factor 12, transcript variant X3
Rho guanine nucleotide exchange factor 12, transcript variant X5
Rho guanine nucleotide exchange factor 12, transcript variant X4
rho guanine nucleotide exchange factor 12 isoform X2
rho guanine nucleotide exchange factor 12 isoform X1
rho guanine nucleotide exchange factor 12 isoform X3
TLC domain-containing protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TLC domain-containing protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 2, transcription factor 3
tripartite motif containing 29, transcript variant X1
tripartite motif-containing protein 29 isoform X1
tripartite motif containing 29, transcript variant X2
tripartite motif-containing protein 29 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53% coverage of the annotated genomic feature by RNAseq alignments
nectin cell adhesion molecule 1, transcript variant X2
nectin cell adhesion molecule 1, transcript variant X4
nectin cell adhesion molecule 1, transcript variant X1
nectin cell adhesion molecule 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X5
nectin cell adhesion molecule 1, transcript variant X3
uncharacterized LOC122463542, transcript variant X2
uncharacterized LOC122463542, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC119564021, transcript variant X4
uncharacterized LOC119564021, transcript variant X8
uncharacterized LOC119564021, transcript variant X2
uncharacterized LOC119564021, transcript variant X5
uncharacterized LOC119564021, transcript variant X3
uncharacterized LOC119564021, transcript variant X7
uncharacterized LOC119564021, transcript variant X6
uncharacterized LOC119564021, transcript variant X1
uncharacterized LOC122463546, transcript variant X1
uncharacterized LOC122463546, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Thy-1 cell surface antigen, transcript variant X1
Thy-1 cell surface antigen, transcript variant X2
ubiquitin specific peptidase 2, transcript variant X2
ubiquitin specific peptidase 2, transcript variant X1
ubiquitin specific peptidase 2, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 2 isoform X1
ubiquitin specific peptidase 2, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 2 isoform X2
membrane frizzled-related protein, transcript variant X2
membrane frizzled-related protein, transcript variant X1
membrane frizzled-related protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
membrane frizzled-related protein isoform X1
membrane frizzled-related protein isoform X2
membrane frizzled-related protein isoform X3
complement C1q tumor necrosis factor-related protein 5
ring finger protein 26, transcript variant X2
ring finger protein 26, transcript variant X1
melanoma cell adhesion molecule, transcript variant X3
melanoma cell adhesion molecule, transcript variant X4
melanoma cell adhesion molecule, transcript variant X7
melanoma cell adhesion molecule, transcript variant X9
melanoma cell adhesion molecule, transcript variant X8
melanoma cell adhesion molecule, transcript variant X1
melanoma cell adhesion molecule, transcript variant X5
melanoma cell adhesion molecule, transcript variant X2
melanoma cell adhesion molecule, transcript variant X6
cell surface glycoprotein MUC18 isoform X1
cell surface glycoprotein MUC18 isoform X5
cell surface glycoprotein MUC18 isoform X2
cell surface glycoprotein MUC18 isoform X6
cell surface glycoprotein MUC18 isoform X3
cell surface glycoprotein MUC18 isoform X4
cell surface glycoprotein MUC18 isoform X7
cell surface glycoprotein MUC18 isoform X8
cell surface glycoprotein MUC18 isoform X9
coiled-coil domain containing 153, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
coiled-coil domain containing 153, transcript variant X2
coiled-coil domain-containing protein 153
PDZ domain containing 3, transcript variant X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X2
PDZ domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X1
NLR family member X1, transcript variant X4
NLR family member X1, transcript variant X1
NLR family member X1, transcript variant X3
NLR family member X1, transcript variant X2
NLR family member X1, transcript variant X5
NLR family member X1, transcript variant X6
ATP binding cassette subfamily G member 4, transcript variant X4
ATP binding cassette subfamily G member 4, transcript variant X2
ATP binding cassette subfamily G member 4, transcript variant X3
ATP binding cassette subfamily G member 4, transcript variant X1
ATP-binding cassette sub-family G member 4 isoform X2
ATP-binding cassette sub-family G member 4 isoform X1
ATP-binding cassette sub-family G member 4 isoform X3
uncharacterized LOC122463557, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122463557, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUB and sushi domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
histone H4 transcription factor, transcript variant X1
histone H4 transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 3 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C11orf53 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
POU class 2 homeobox associating factor 1, transcript variant X1
POU class 2 homeobox associating factor 1, transcript variant X2
POU domain class 2-associating factor 1 isoform X2
POU domain class 2-associating factor 1 isoform X1
POU class 2 homeobox associating factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
POU domain class 2-associating factor 1 isoform X3
uncharacterized LOC122463522, transcript variant X1
POU class 2 homeobox associating factor 1, transcript variant X4
POU domain class 2-associating factor 1 isoform X4
uncharacterized LOC122463522, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 82% coverage of the annotated genomic feature by RNAseq alignments
BTG anti-proliferation factor 4, transcript variant X1
BTG anti-proliferation factor 4, transcript variant X3
BTG anti-proliferation factor 4, transcript variant X2
HOATZ cilia and flagella associated protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
cilia- and flagella-associated protein HOATZ
salt inducible kinase 2, transcript variant X1
salt inducible kinase 2, transcript variant X2
salt inducible kinase 2, transcript variant X3
serine/threonine-protein kinase SIK2 isoform X1
serine/threonine-protein kinase SIK2 isoform X2
serine/threonine-protein kinase SIK2 isoform X3
salt inducible kinase 2, transcript variant X4
salt inducible kinase 2, transcript variant X6
serine/threonine-protein kinase SIK2 isoform X4
serine/threonine-protein kinase SIK2 isoform X6
salt inducible kinase 2, transcript variant X7
salt inducible kinase 2, transcript variant X5
serine/threonine-protein kinase SIK2 isoform X5
serine/threonine-protein kinase SIK2 isoform X7
ALG9 alpha-1,2-mannosyltransferase, transcript variant X7
ALG9 alpha-1,2-mannosyltransferase, transcript variant X6
alpha-1,2-mannosyltransferase ALG9 isoform X4
ALG9 alpha-1,2-mannosyltransferase, transcript variant X10
ALG9 alpha-1,2-mannosyltransferase, transcript variant X4
ALG9 alpha-1,2-mannosyltransferase, transcript variant X8
alpha-1,2-mannosyltransferase ALG9 isoform X7
alpha-1,2-mannosyltransferase ALG9 isoform X2
alpha-1,2-mannosyltransferase ALG9 isoform X5
ALG9 alpha-1,2-mannosyltransferase, transcript variant X1
ALG9 alpha-1,2-mannosyltransferase, transcript variant X3
ALG9 alpha-1,2-mannosyltransferase, transcript variant X2
ALG9 alpha-1,2-mannosyltransferase, transcript variant X11
ALG9 alpha-1,2-mannosyltransferase, transcript variant X9
ALG9 alpha-1,2-mannosyltransferase, transcript variant X5
alpha-1,2-mannosyltransferase ALG9 isoform X1
alpha-1,2-mannosyltransferase ALG9 isoform X8
alpha-1,2-mannosyltransferase ALG9 isoform X6
alpha-1,2-mannosyltransferase ALG9 isoform X3
chromosome 22 C11orf1 homolog, transcript variant X2
heat shock protein family B (small) member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromosome 22 C11orf1 homolog, transcript variant X1
chromosome 22 C11orf1 homolog, transcript variant X3
heat shock protein family B (small) member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
chromosome 22 C11orf52 homolog, transcript variant X1
chromosome 22 C11orf52 homolog, transcript variant X2
uncharacterized protein C11orf52 homolog isoform X1
uncharacterized protein C11orf52 homolog isoform X2
DIX domain containing 1, transcript variant X2
DIX domain containing 1, transcript variant X3
DIX domain containing 1, transcript variant X1
DIX domain containing 1, transcript variant X4
DIX domain containing 1, transcript variant X5
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial
PIH1 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
PIH1 domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
PIH1 domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
PIH1 domain-containing protein 2 isoform X1
PIH1 domain-containing protein 2 isoform X2
NKAP domain containing 1, transcript variant X1
NKAP domain containing 1, transcript variant X2
translocase of inner mitochondrial membrane 8 homolog B
mitochondrial import inner membrane translocase subunit Tim8 B
beta,beta-carotene 9',10'-oxygenase, transcript variant X1
beta,beta-carotene 9',10'-oxygenase, transcript variant X3
beta,beta-carotene 9',10'-oxygenase isoform X1
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial isoform X3
beta,beta-carotene 9',10'-oxygenase, transcript variant X4
beta,beta-carotene 9',10'-oxygenase isoform X4
beta,beta-carotene 9',10'-oxygenase, transcript variant X2
beta,beta-carotene 9',10'-oxygenase isoform X2
placenta-expressed transcript 1 protein, transcript variant X1
placenta-expressed transcript 1 protein, transcript variant X2
uncharacterized LOC122463572, transcript variant X2
uncharacterized LOC122463572, transcript variant X1
neural cell adhesion molecule 1, transcript variant X1
neural cell adhesion molecule 1, transcript variant X9
neural cell adhesion molecule 1, transcript variant X4
neural cell adhesion molecule 1 isoform X1
neural cell adhesion molecule 1 isoform X9
neural cell adhesion molecule 1 isoform X4
neural cell adhesion molecule 1, transcript variant X2
neural cell adhesion molecule 1, transcript variant X7
neural cell adhesion molecule 1, transcript variant X3
neural cell adhesion molecule 1, transcript variant X8
neural cell adhesion molecule 1, transcript variant X5
neural cell adhesion molecule 1, transcript variant X6
neural cell adhesion molecule 1 isoform X2
neural cell adhesion molecule 1 isoform X5
neural cell adhesion molecule 1 isoform X3
neural cell adhesion molecule 1 isoform X6
neural cell adhesion molecule 1 isoform X7
neural cell adhesion molecule 1 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tetratricopeptide repeat domain 12, transcript variant X1
tetratricopeptide repeat domain 12, transcript variant X2
tetratricopeptide repeat domain 12, transcript variant X4
tetratricopeptide repeat domain 12, transcript variant X3
tetratricopeptide repeat protein 12 isoform X1
tetratricopeptide repeat protein 12 isoform X2
tetratricopeptide repeat protein 12 isoform X3
ankyrin repeat and kinase domain containing 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 36% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ankyrin repeat and protein kinase domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane serine protease 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protease serine 5 isoform X1
transmembrane serine protease 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protease serine 5 isoform X2
zw10 kinetochore protein, transcript variant X1
zw10 kinetochore protein, transcript variant X2
centromere/kinetochore protein zw10 homolog isoform X1
centromere/kinetochore protein zw10 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin specific peptidase 28, transcript variant X9
ubiquitin specific peptidase 28, transcript variant X3
ubiquitin specific peptidase 28, transcript variant X7
ubiquitin specific peptidase 28, transcript variant X5
ubiquitin specific peptidase 28, transcript variant X2
ubiquitin specific peptidase 28, transcript variant X1
ubiquitin specific peptidase 28, transcript variant X10
ubiquitin specific peptidase 28, transcript variant X4
ubiquitin specific peptidase 28, transcript variant X11
ubiquitin specific peptidase 28, transcript variant X8
ubiquitin specific peptidase 28, transcript variant X6
ubiquitin specific peptidase 28, transcript variant X12
ubiquitin specific peptidase 28, transcript variant X13
ubiquitin carboxyl-terminal hydrolase 28 isoform X9
ubiquitin carboxyl-terminal hydrolase 28 isoform X3
ubiquitin carboxyl-terminal hydrolase 28 isoform X7
ubiquitin carboxyl-terminal hydrolase 28 isoform X5
ubiquitin carboxyl-terminal hydrolase 28 isoform X2
ubiquitin carboxyl-terminal hydrolase 28 isoform X1
ubiquitin carboxyl-terminal hydrolase 28 isoform X10
ubiquitin carboxyl-terminal hydrolase 28 isoform X8
ubiquitin carboxyl-terminal hydrolase 28 isoform X6
ubiquitin carboxyl-terminal hydrolase 28 isoform X4
ubiquitin carboxyl-terminal hydrolase 28 isoform X12
ubiquitin carboxyl-terminal hydrolase 28 isoform X11
ubiquitin carboxyl-terminal hydrolase 28 isoform X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain containing 16, transcript variant X4
zinc finger and BTB domain containing 16, transcript variant X5
zinc finger and BTB domain containing 16, transcript variant X1
zinc finger and BTB domain containing 16, transcript variant X2
zinc finger and BTB domain containing 16, transcript variant X3
zinc finger and BTB domain-containing protein 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA binding motif protein 7, transcript variant X2
RNA binding motif protein 7, transcript variant X1
RNA binding motif protein 7, transcript variant X3
RNA binding motif protein 7, transcript variant X4
neurexophilin and PC-esterase domain family member 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NXPE family member 1
uncharacterized LOC122463530, transcript variant X4
uncharacterized LOC122463530, transcript variant X1
uncharacterized LOC122463530, transcript variant X2
uncharacterized LOC122463530, transcript variant X3
cell adhesion molecule 1, transcript variant X4
cell adhesion molecule 1, transcript variant X2
cell adhesion molecule 1, transcript variant X6
cell adhesion molecule 1, transcript variant X1
cell adhesion molecule 1, transcript variant X3
cell adhesion molecule 1, transcript variant X5
uncharacterized LOC122463567, transcript variant X1
uncharacterized LOC122463567, transcript variant X2
uncharacterized LOC122463569, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122463569, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
stabilizer of axonemal microtubules 1, transcript variant X1
stabilizer of axonemal microtubules 1, transcript variant X2
stabilizer of axonemal microtubules 1 isoform X1
stabilizer of axonemal microtubules 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SIK family kinase 3, transcript variant X6
SIK family kinase 3, transcript variant X10
SIK family kinase 3, transcript variant X7
SIK family kinase 3, transcript variant X14
SIK family kinase 3, transcript variant X13
SIK family kinase 3, transcript variant X3
SIK family kinase 3, transcript variant X2
SIK family kinase 3, transcript variant X1
SIK family kinase 3, transcript variant X15
SIK family kinase 3, transcript variant X5
SIK family kinase 3, transcript variant X4
SIK family kinase 3, transcript variant X12
SIK family kinase 3, transcript variant X11
SIK family kinase 3, transcript variant X8
SIK family kinase 3, transcript variant X9
serine/threonine-protein kinase SIK3 isoform X11
serine/threonine-protein kinase SIK3 isoform X8
serine/threonine-protein kinase SIK3 isoform X9
serine/threonine-protein kinase SIK3 isoform X6
serine/threonine-protein kinase SIK3 isoform X5
serine/threonine-protein kinase SIK3 isoform X4
serine/threonine-protein kinase SIK3 isoform X3
serine/threonine-protein kinase SIK3 isoform X10
serine/threonine-protein kinase SIK3 isoform X2
serine/threonine-protein kinase SIK3 isoform X1
serine/threonine-protein kinase SIK3 isoform X7
SIK family kinase 3, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
serine/threonine-protein kinase SIK3 isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X4
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X1
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X3
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X3
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X1
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X2
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X2
SID1 transmembrane family member 2, transcript variant X2
SID1 transmembrane family member 2, transcript variant X1
SID1 transmembrane family member 2 isoform X1
SID1 transmembrane family member 2 isoform X2
SID1 transmembrane family member 2, transcript variant X3
SID1 transmembrane family member 2 isoform X3
palmitoyl-protein thioesterase ABHD10, mitochondrial, transcript variant X4
palmitoyl-protein thioesterase ABHD10, mitochondrial, transcript variant X5
palmitoyl-protein thioesterase ABHD10, mitochondrial, transcript variant X6
palmitoyl-protein thioesterase ABHD10, mitochondrial, transcript variant X3
palmitoyl-protein thioesterase ABHD10, mitochondrial, transcript variant X1
palmitoyl-protein thioesterase ABHD10, mitochondrial, transcript variant X2
palmitoyl-protein thioesterase ABHD10, mitochondrial
proprotein convertase subtilisin/kexin type 7, transcript variant X3
proprotein convertase subtilisin/kexin type 7, transcript variant X2
proprotein convertase subtilisin/kexin type 7, transcript variant X1
proprotein convertase subtilisin/kexin type 7 isoform X3
proprotein convertase subtilisin/kexin type 7 isoform X2
proprotein convertase subtilisin/kexin type 7 isoform X1
ring finger protein 214, transcript variant X6
ring finger protein 214, transcript variant X7
ring finger protein 214, transcript variant X1
ring finger protein 214, transcript variant X2
ring finger protein 214, transcript variant X3
ring finger protein 214, transcript variant X4
ring finger protein 214, transcript variant X5
centrosomal protein 164, transcript variant X11
centrosomal protein 164, transcript variant X27
centrosomal protein 164, transcript variant X30
centrosomal protein 164, transcript variant X3
centrosomal protein 164, transcript variant X8
centrosomal protein 164, transcript variant X10
centrosomal protein 164, transcript variant X9
centrosomal protein 164, transcript variant X14
centrosomal protein 164, transcript variant X15
centrosomal protein 164, transcript variant X1
centrosomal protein 164, transcript variant X7
centrosomal protein 164, transcript variant X4
centrosomal protein 164, transcript variant X5
centrosomal protein 164, transcript variant X6
centrosomal protein 164, transcript variant X12
centrosomal protein 164, transcript variant X13
centrosomal protein 164, transcript variant X17
centrosomal protein 164, transcript variant X19
centrosomal protein 164, transcript variant X21
centrosomal protein 164, transcript variant X26
centrosomal protein 164, transcript variant X29
centrosomal protein 164, transcript variant X18
centrosomal protein 164, transcript variant X20
centrosomal protein 164, transcript variant X25
centrosomal protein 164, transcript variant X28
centrosomal protein 164, transcript variant X22
centrosomal protein 164, transcript variant X23
centrosomal protein 164, transcript variant X24
centrosomal protein 164, transcript variant X31
centrosomal protein 164, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
centrosomal protein 164, transcript variant X2
centrosomal protein of 164 kDa isoform X1
centrosomal protein of 164 kDa isoform X5
centrosomal protein of 164 kDa isoform X2
centrosomal protein of 164 kDa isoform X3
centrosomal protein of 164 kDa isoform X6
centrosomal protein of 164 kDa isoform X4
centrosomal protein of 164 kDa isoform X7
centrosomal protein of 164 kDa isoform X8
centrosomal protein of 164 kDa isoform X10
centrosomal protein of 164 kDa isoform X12
centrosomal protein of 164 kDa isoform X14
centrosomal protein of 164 kDa isoform X19
centrosomal protein of 164 kDa isoform X22
centrosomal protein of 164 kDa isoform X11
centrosomal protein of 164 kDa isoform X13
centrosomal protein of 164 kDa isoform X18
centrosomal protein of 164 kDa isoform X21
centrosomal protein of 164 kDa isoform X20
centrosomal protein of 164 kDa isoform X23
centrosomal protein of 164 kDa isoform X15
centrosomal protein of 164 kDa isoform X16
centrosomal protein of 164 kDa isoform X17
centrosomal protein of 164 kDa isoform X24
centrosomal protein of 164 kDa isoform X9
DS cell adhesion molecule like 1, transcript variant X1
DS cell adhesion molecule like 1, transcript variant X2
Down syndrome cell adhesion molecule-like protein 1 isoform X1
Down syndrome cell adhesion molecule-like protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane serine protease 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane serine protease 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane serine protease 4, transcript variant X3
transmembrane serine protease 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protease serine 4 isoform X1
transmembrane protease serine 4 isoform X2
transmembrane protease serine 4 isoform X3
transmembrane protease serine 4 isoform X4
sodium voltage-gated channel beta subunit 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
sodium voltage-gated channel beta subunit 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium channel subunit beta-4 isoform X1
sodium channel subunit beta-4 isoform X2
sodium voltage-gated channel beta subunit 2
junction adhesion molecule like, transcript variant X1
junction adhesion molecule like, transcript variant X2
junction adhesion molecule like, transcript variant X3
myelin protein zero-like protein 3, transcript variant X2
myelin protein zero-like protein 3, transcript variant X1
myelin protein zero-like protein 3 isoform X2
myelin protein zero-like protein 3 isoform X1
myelin protein zero like 2, transcript variant X1
myelin protein zero like 2, transcript variant X2
myelin protein zero-like protein 2 isoform X1
myelin protein zero-like protein 2 isoform X2
T-cell surface glycoprotein CD3 epsilon chain isoform X1
T-cell surface glycoprotein CD3 epsilon chain isoform X2
T-cell surface glycoprotein CD3 gamma chain isoform X1
T-cell surface glycoprotein CD3 gamma chain isoform X2
ubiquitination factor E4A, transcript variant X1
ubiquitination factor E4A, transcript variant X6
ubiquitination factor E4A, transcript variant X4
ubiquitination factor E4A, transcript variant X8
ubiquitination factor E4A, transcript variant X7
ubiquitination factor E4A, transcript variant X3
ubiquitination factor E4A, transcript variant X2
ubiquitination factor E4A, transcript variant X5
ubiquitin conjugation factor E4 A isoform X1
ubiquitin conjugation factor E4 A isoform X2
lysine methyltransferase 2A, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
lysine methyltransferase 2A, transcript variant X1
lysine methyltransferase 2A, transcript variant X4
lysine methyltransferase 2A, transcript variant X2
lysine methyltransferase 2A, transcript variant X5
lysine methyltransferase 2A, transcript variant X6
lysine methyltransferase 2A, transcript variant X3
lysine methyltransferase 2A, transcript variant X7
histone-lysine N-methyltransferase 2A isoform X1
histone-lysine N-methyltransferase 2A isoform X4
histone-lysine N-methyltransferase 2A isoform X2
histone-lysine N-methyltransferase 2A isoform X5
histone-lysine N-methyltransferase 2A isoform X6
histone-lysine N-methyltransferase 2A isoform X3
histone-lysine N-methyltransferase 2A isoform X7
histone-lysine N-methyltransferase 2A isoform X8
tetratricopeptide repeat domain 36, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tetratricopeptide repeat domain 36, transcript variant X5
tetratricopeptide repeat domain 36, transcript variant X1
tetratricopeptide repeat domain 36, transcript variant X2
tetratricopeptide repeat protein 36 isoform X1
tetratricopeptide repeat protein 36 isoform X3
tetratricopeptide repeat domain 36, transcript variant X4
tetratricopeptide repeat protein 36 isoform X2
transmembrane protein 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
transmembrane protein 25, transcript variant X3
transmembrane protein 25, transcript variant X1
intraflagellar transport 46, transcript variant X8
intraflagellar transport 46, transcript variant X5
intraflagellar transport 46, transcript variant X2
intraflagellar transport 46, transcript variant X10
intraflagellar transport 46, transcript variant X6
intraflagellar transport 46, transcript variant X3
intraflagellar transport 46, transcript variant X7
intraflagellar transport 46, transcript variant X9
intraflagellar transport 46, transcript variant X4
intraflagellar transport 46, transcript variant X1
intraflagellar transport protein 46 homolog isoform X3
intraflagellar transport protein 46 homolog isoform X2
intraflagellar transport protein 46 homolog isoform X1
intraflagellar transport protein 46 homolog isoform X4
pleckstrin homology like domain family B member 1, transcript variant X5
pleckstrin homology like domain family B member 1, transcript variant X27
pleckstrin homology like domain family B member 1, transcript variant X30
pleckstrin homology like domain family B member 1, transcript variant X6
pleckstrin homology like domain family B member 1, transcript variant X1
pleckstrin homology like domain family B member 1, transcript variant X3
pleckstrin homology like domain family B member 1, transcript variant X9
pleckstrin homology like domain family B member 1, transcript variant X19
pleckstrin homology like domain family B member 1, transcript variant X8
pleckstrin homology like domain family B member 1, transcript variant X4
pleckstrin homology like domain family B member 1, transcript variant X7
pleckstrin homology like domain family B member 1, transcript variant X12
pleckstrin homology like domain family B member 1, transcript variant X11
pleckstrin homology like domain family B member 1, transcript variant X2
pleckstrin homology like domain family B member 1, transcript variant X13
pleckstrin homology like domain family B member 1, transcript variant X18
pleckstrin homology like domain family B member 1, transcript variant X16
pleckstrin homology like domain family B member 1, transcript variant X17
pleckstrin homology like domain family B member 1, transcript variant X20
pleckstrin homology like domain family B member 1, transcript variant X24
pleckstrin homology like domain family B member 1, transcript variant X28
pleckstrin homology like domain family B member 1, transcript variant X22
pleckstrin homology like domain family B member 1, transcript variant X23
pleckstrin homology like domain family B member 1, transcript variant X25
pleckstrin homology like domain family B member 1, transcript variant X21
pleckstrin homology like domain family B member 1, transcript variant X26
pleckstrin homology like domain family B member 1, transcript variant X29
pleckstrin homology-like domain family B member 1 isoform X1
pleckstrin homology-like domain family B member 1 isoform X4
pleckstrin homology-like domain family B member 1 isoform X3
pleckstrin homology-like domain family B member 1 isoform X6
pleckstrin homology-like domain family B member 1 isoform X11
pleckstrin homology-like domain family B member 1 isoform X10
pleckstrin homology-like domain family B member 1 isoform X7
pleckstrin homology-like domain family B member 1 isoform X12
pleckstrin homology-like domain family B member 1 isoform X16
pleckstrin homology-like domain family B member 1 isoform X22
pleckstrin homology-like domain family B member 1 isoform X8
pleckstrin homology-like domain family B member 1 isoform X26
pleckstrin homology-like domain family B member 1 isoform X2
pleckstrin homology-like domain family B member 1 isoform X14
pleckstrin homology-like domain family B member 1 isoform X15
pleckstrin homology-like domain family B member 1 isoform X19
pleckstrin homology-like domain family B member 1 isoform X18
pleckstrin homology-like domain family B member 1 isoform X20
pleckstrin homology-like domain family B member 1 isoform X17
pleckstrin homology-like domain family B member 1 isoform X21
pleckstrin homology-like domain family B member 1 isoform X23
pleckstrin homology-like domain family B member 1 isoform X24
pleckstrin homology-like domain family B member 1 isoform X27
pleckstrin homology like domain family B member 1, transcript variant X10
pleckstrin homology-like domain family B member 1 isoform X5
pleckstrin homology-like domain family B member 1 isoform X25
pleckstrin homology-like domain family B member 1 isoform X28
pleckstrin homology-like domain family B member 1 isoform X9
pleckstrin homology like domain family B member 1, transcript variant X14
pleckstrin homology like domain family B member 1, transcript variant X15
pleckstrin homology-like domain family B member 1 isoform X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
DEAD-box helicase 6, transcript variant X2
DEAD-box helicase 6, transcript variant X1
DEAD-box helicase 6, transcript variant X3
probable ATP-dependent RNA helicase DDX6
B-cell CLL/lymphoma 9-like protein isoform X2
B-cell CLL/lymphoma 9-like protein isoform X1
nascent polypeptide-associated complex subunit alpha, muscle-specific form
trafficking protein particle complex subunit 4, transcript variant X2
trafficking protein particle complex subunit 4, transcript variant X1
trafficking protein particle complex subunit 4 isoform X1
trafficking protein particle complex subunit 4 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: glucose-6-phosphate exchanger SLC37A4
hypoxia up-regulated 1, transcript variant X1
hypoxia up-regulated 1, transcript variant X3
hypoxia up-regulated 1, transcript variant X2
hypoxia up-regulated 1, transcript variant X4
hypoxia up-regulated 1, transcript variant X6
hypoxia up-regulated 1, transcript variant X5
hypoxia up-regulated protein 1 isoform X1
hypoxia up-regulated protein 1 isoform X2
VPS11 core subunit of CORVET and HOPS complexes
vacuolar protein sorting-associated protein 11 homolog
hydroxymethylbilane synthase, transcript variant X1
hydroxymethylbilane synthase, transcript variant X2
hydroxymethylbilane synthase, transcript variant X3
hydroxymethylbilane synthase, transcript variant X4
hydroxymethylbilane synthase, transcript variant X6
hydroxymethylbilane synthase, transcript variant X5
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
phospholipid transfer protein C2CD2L isoform X1
phospholipid transfer protein C2CD2L isoform X3
phospholipid transfer protein C2CD2L isoform X2
phospholipid transfer protein C2CD2L isoform X4
phospholipid transfer protein C2CD2L isoform X6
phospholipid transfer protein C2CD2L isoform X8
phospholipid transfer protein C2CD2L isoform X7
phospholipid transfer protein C2CD2L isoform X9
phospholipid transfer protein C2CD2L isoform X5
phospholipid transfer protein C2CD2L isoform X10
zinc finger protein 3, transcript variant X46
zinc finger protein 3, transcript variant X47
zinc finger protein 3, transcript variant X39
zinc finger protein 3, transcript variant X45
zinc finger protein 3, transcript variant X4
zinc finger protein 3, transcript variant X15
zinc finger protein 3, transcript variant X25
zinc finger protein 3, transcript variant X20
zinc finger protein 3, transcript variant X26
zinc finger protein 3, transcript variant X5
zinc finger protein 3, transcript variant X11
zinc finger protein 3, transcript variant X7
zinc finger protein 3, transcript variant X10
zinc finger protein 3, transcript variant X12
zinc finger protein 3, transcript variant X2
zinc finger protein 3, transcript variant X14
zinc finger protein 3, transcript variant X3
zinc finger protein 3, transcript variant X8
zinc finger protein 3, transcript variant X6
zinc finger protein 3, transcript variant X13
zinc finger protein 3, transcript variant X9
zinc finger protein 3, transcript variant X22
zinc finger protein 3, transcript variant X30
zinc finger protein 3, transcript variant X1
zinc finger protein 3, transcript variant X21
zinc finger protein 3, transcript variant X23
zinc finger protein 3, transcript variant X29
zinc finger protein 3, transcript variant X16
zinc finger protein 3, transcript variant X31
zinc finger protein 3, transcript variant X35
zinc finger protein 3, transcript variant X40
zinc finger protein 3, transcript variant X42
zinc finger protein 3, transcript variant X41
zinc finger protein 3, transcript variant X44
zinc finger protein 3, transcript variant X43
zinc finger protein 3, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 3, transcript variant X33
zinc finger protein 3, transcript variant X17
zinc finger protein 3, transcript variant X27
zinc finger protein 3, transcript variant X18
zinc finger protein 3, transcript variant X32
zinc finger protein 3, transcript variant X34
zinc finger protein 3, transcript variant X37
zinc finger protein 3, transcript variant X36
zinc finger protein 3, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein 3, transcript variant X28
zinc finger protein 3, transcript variant X38